Every finance team wants a complete and accurate picture of how the organisation is doing, as quickly as possible.

Amgen has spoken out about concerns related to bone mineral density (BMD) loss with its obesity candidate after an analyst’s comment caused a $12bn market wipe.

Ready to start building a dividend portfolio from scratch? In this video, I share a step-by-step roadmap for creating a cash ...

The ASX stock has consistently reflected a number of other desirable ... I keep tabs on this by adding to a spreadsheet each ...

Virtus Convertible & Income Fund II's (NCZ) preferred shares (NCZ.PR.A) are rated “A” by Fitch. See why I still rate the ...

Ulta Beauty revised its guidance downward, indicating a departure from its historical EPS growth. Find out what leads to a ...